Vicore Pharma Holding AB

NASDAQ: VCRE · Healthcare · Medical - Pharmaceuticals

PublicHQ Solna, CIK 0002124403Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 46

v0.1 · 5/100 weight · pillars only

↑ market scale, workforce scale · ↓ listing tenure, workforce scale

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

Market cap

$3.9B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Vicore Pharma Holding AB has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Dianthus Therapeutics, Inc.49D ICU Medical, Inc.78B+Catalyst Pharmaceuticals, Inc.82B+Dyne Therapeutics, Inc.——

Key facts

CEOAhmed Mousa

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersSolna, null

ExchangeNASDAQ: VCRE

Employees37

IPO date2026-07-02

Latest filings

6-K2026-07-06

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.